[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Unidade Local de Saúde São João\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":100},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,72],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100639952","mobile-app-vs-in-person-pelvic-floor-rehabilitation-for-urinary-leakage-in-adult-women-100639952",false,"NCT07597174","Mobile App vs. In-Person Pelvic Floor Rehabilitation for Urinary Leakage in Adult Women","Randomized Controlled Non-Inferiority Trial Comparing a Mobile Application Based Program With Conventional Rehabilitation for Stress and Mixed Urinary Incontinence in Adult Women","Inclusion Criteria:\n\n* age \\>18 years\n* stress urinary incontinence (SUI) or mixed urinary incontinence with predominance of SUI\n* more than one urinary incontinence episode for week in the last month\n* pelvic floor muscle strength equal or greater than 2 assessed by Oxford Modified Rating Score\n\nExclusion Criteria:\n\n* indwelling urinary catheter\n* active pelvic neoplasia\n* pelvic organ prolapse grade greater than or equal to 2\n* active urinary tract infection or macroscopic hematuria\n* neurogenic dysfunction of the lower urinary tract\n* cognitive deficit, osteoarticular, neurological or psychiatric pathologies that prevent the realization of the therapeutic program\n* conservative or surgical treatment of UI in the last 12 months\n* pregnancy or recent childbirth (\\\u003C 6 months)\n* impossibility of access or illiteracy to technological means (smartphone)\n* unavailability to attend the supervised program due to accessibility, schedule or economic reasons","FEMALE","18 Years",{"count":19,"type":20},32,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to learn if a mobile app-guided pelvic floor rehabilitation program works as well as standard in-person pelvic floor rehabilitation to treat urinary leakage in adult women.\n\nThe main question it aims to answer is:\n\nDoes the app program improve quality of life related to urinary leakage as much as in-person rehabilitation?\n\nResearchers will compare the app-based program to in-person rehabilitation to see if both lead to similar improvements in quality of life.\n\nParticipants will:\n\nAttend one medical visit before starting to confirm they are eligible Attend one in-person training session with a physiotherapist Follow either an app-based or an in-person pelvic floor rehabilitation program for 3 months Complete quality of life questionnaires at the start and at 4 months",[26],"Urinary Incontinence , Stress",[28,29,30],"mobile app","urinary incontinence","woman","RECRUITING","2026-05-19",{"date":34,"type":35},"2026-05-22","ACTUAL",{"date":37,"type":35},"2026-03-26",{"date":39,"type":20},"2026-08-21",{"name":41,"class":42},"Unidade Local de Saúde São João","OTHER_GOV",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":54,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":4},"100637554","portuguese-mobile-app-version-of-the-iciq-bladder-diary-for-adults-with-urinary-symptoms-development-and-feasibility-study-100637554","NCT07602413","Portuguese Mobile App Version of the ICIQ Bladder Diary for Adults With Urinary Symptoms: Development and Feasibility Study","Development and Feasibility of the Portuguese Version of the ICIQ-bladder Diary as a Mobile Application","Inclusion Criteria\n\n* Adults aged 18 years or older\n* Diagnosis of overactive bladder and\u002For urinary incontinence for at least 6 months\n* Previous experience completing a paper bladder diary\n* Own and regularly use a smartphone\n* Able to understand and use the My São João App and the Diário da Bexiga VD mobile application\n* Able and willing to provide informed consent\n\nExclusion Criteria\n\n* Unable to understand, read, speak, or write Portuguese\n* No regular access to the internet during the study period\n* Unable to use a smartphone application independently","ALL",{"count":53,"type":20},40,"1 Month","OBSERVATIONAL","The goal of this clinical trial is to evaluate a mobile app version of the International Consultation on Incontinence Questionnaire Bladder Diary (ICIQ-Bladder Diary) in Portuguese adults with urinary symptoms. The study aims to learn whether an electronic bladder diary is feasible, easy to use, and well accepted by participants and physicians.\n\nThe main questions it aims to answer are:\n\nIs the mobile app feasible, based on the percentage of participants who completely fill in the diary over 1 month? Do participants consider the app to be high quality and easy to use? Do participants and physicians prefer the electronic diary over paper formats?\n\nParticipants will:\n\nUse the mobile app version of the ICIQ-Bladder Diary for 1 month; Complete questionnaires about app quality, usability, and preference, including the User Mobile App Rating Scale (uMARS).\n\nSix rehabilitation physicians will review the completed diaries and answer questions about ease of interpretation and preferred diary format.\n\nThe investigators expect the app to be feasible and well accepted by both participants and physicians. If successful, the app may support wider use of electronic bladder diaries in clinical practice in Portugal.",[58],"Lower Urinary Tract Symptoms (LUTS)",[60,61,62,28,63],"Bladder diary","incontinence","smartphone","electronic diary","NOT_YET_RECRUITING","2026-05-18",{"date":34,"type":35},{"date":68,"type":20},"2026-05-25",{"date":70,"type":20},"2026-08-31",{"name":41,"class":42},{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":4,"enrollmentInfo":79,"targetDuration":4,"studyType":21,"phases":81,"briefSummary":82,"conditions":83,"keywords":86,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":5},"100630880","to-evaluate-the-feasibility-and-safety-of-combining-surgery-pancreatectomy-and-cytoreduction-with-hipec-for-treating-pancreatic-cancer-with-peritoneal-involvement-100630880","NCT07493421","To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.","Cytoreductive Surgery and HIPEC for Pancreatic Cancer With Peritoneal Metastasis - IGNIS Trial","Inclusion Criteria:\n\n* Pancreatic adenocarcinoma\n* Histologically confirmed peritoneal metastasis\n* Excluded other sites of metastasis (except ovary)\n* PCI less than or equal to 6\n* Age \\> 18 years\n* ECOG performance status 0-1\n* Written informed consent\n\nExclusion Criteria:\n\n* Pregnancy\n* Intestinal obstruction\n* Renal insufficiency (GFR \\\u003C 45 ml\u002Fmin)",{"count":80,"type":20},20,[23],"The goal of this clinical trial is to evaluate the safety and feasibility of a combined surgical and chemotherapy approach (pancreatectomy with cytoreductive surgery and HIPEC) in patients aged 18 and older with pancreatic ductal adenocarcinoma and synchronous peritoneal metastases. The main questions it aims to answer are:\n\nIs the 90-day mortality rate for this intensive combined procedure lower than 5%? What are the postoperative morbidity and complication rates (as measured by the Clavien-Dindo classification) for these patients? How does this treatment impact the patient's quality of life 12 months after the procedure?\n\nParticipants will:\n\nComplete at least 6 months of systemic chemotherapy to ensure the disease is stable or responding (biomarker CA19-9 must decline by \\>20%).\n\nUndergo a major surgical procedure involving the removal of the pancreatic tumour (total Pancreatectomy or RAMPS) and any visible abdominal metastases (Cytoreductive Surgery).\n\nReceive Hyperthermic Intraperitoneal Chemotherapy (HIPEC), where heated Cisplatin and Paclitaxel are circulated in the abdominal cavity for 90 minutes during the operation.\n\nParticipate in long-term follow-up to monitor recurrence-free and overall survival.",[84,85],"Pancreatic Adenocarcinoma","Peritoneal (Metastatic) Cancer",[87,88,89,90,91],"Pancreatic Cancer","Cytoreduction Surgical Procedures","Hyperthermic Intraperitoneal Chemotherapy","Peritoneal Metastasis","Peritoneal Carcinomatosis","2026-03-20",{"date":94,"type":35},"2026-03-25",{"date":96,"type":35},"2026-03-01",{"date":98,"type":20},"2028-10-01",{"name":41,"class":42},""]